| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5657343 | Clinical Gastroenterology and Hepatology | 2016 | 24 Pages |
Abstract
A retrospective analysis of patients with PSC treated at tertiary centers in Europe found no evidence that azathioprine significantly affects the risk of CCA. Azathioprine therefore should not be withheld from patients with PSC and concomitant IBD and/or AIH.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Roman Zenouzi, Tobias J. Weismüller, Kristin K. Jørgensen, Michael Bubenheim, Henrike Lenzen, Peter Hübener, Kornelius Schulze, Christina Weiler-Normann, Marcial Sebode, Hanno Ehlken, Nadine Pannicke, Johannes Hartl, Moritz Peiseler, Sina Hübener,